Archive · 7 Aug 2025
Lincoln Pharma's Q1 Results: Net Profit Up 17%, Shares Surge
A company called Lincoln Pharmaceuticals made more money this past quarter compared to last year.
Their profits went up by 17%, and their sales also increased.
They are doing well in specific areas like heart, diabetes, skin, and ear/nose/throat medicines.
The company is planning to grow a lot more in the next few years and make even more money.
Lincoln Pharmaceuticals Ltd. reported its June quarter results.
Net profit increased 17% year-on-year to ₹28 crore.
Revenue grew 5% to ₹154 crore compared to the previous year.
EBITDA rose 4% year-on-year to ₹24 crore.
The company is targeting ₹1,000 crore revenue within three years.
- Who
- Lincoln Pharmaceuticals Ltd.
- What
- Lincoln Pharmaceuticals Ltd. released its June quarter results.
- When
- During the June quarter and reported on Thursday, August 7.
- Where
- Not explicitly mentioned.
- Why
- Not explicitly mentioned, but driven by strong performance in certain segments.
Financial Performance
Market Reaction
Profitability
Financial Performance
Net profit increased to ₹28 crore.
Market Reaction
Details not mentioned.
- Net profit
- ₹28 crore
- Revenue
- ₹154 crore
- EBITDA
- ₹24 crore
- EBITDA margin
- 15%
- Share Price Increase
- 8.05%
- Target Revenue (3 years)
- ₹1,000 crore